Proteomic profiling identifies markers for inflammation-related tumor-fibroblast interaction.

Drev, Daniel; Bileck, Andrea; Erdem, Zeynep N; Mohr, Thomas; Timelthaler, Gerald; Beer, Andrea; Gerner, Christopher; Marian, Brigitte

Drev, Daniel; Bileck, Andrea; Erdem, Zeynep N; Mohr, Thomas; Timelthaler, Gerald; Beer, Andrea; Gerner, Christopher; Marian, Brigitte.

Afiliação

Drev D; Department of Medicine 1, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Bileck A; Institute of Analytical Chemistry, University of Vienna, Vienna, Austria.
Erdem ZN; Department of Medicine 1, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Mohr T; Department of Medicine 1, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Timelthaler G; Department of Medicine 1, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Beer A; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Gerner C; Institute of Analytical Chemistry, University of Vienna, Vienna, Austria.
Marian B; Department of Medicine 1, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Clin Proteomics ; 14: 33, 2017.

Article em En | MEDLINE | ID: mdl-29176937

Palavras-chave

Cancer associated fibroblasts; Colorectal cancer; Extracellular matrix organization; Inflammation signature; Proteomic profiling; SPARC; THBS2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Proteomics Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google